drugset / Trial / NCT01288625

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

NCT01288625

RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to compare the incidence of stomatitis when treating with amifostine before radiation treatment.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown 500 mg Subcutaneous

Indications